Skip to content

BPC-157

Also called Body Protection Compound-157 / Pentadecapeptide

Cytoprotective peptide from gastric juice.

  • TypePeptide
  • FormInjectable, oral, nasal
  • Researched forHealing & Recovery
BPC-157 by AminoWell USA
Photo: AminoWell USA

Where to get BPC-157

AminoWell USA
Injectable
Code CAMERON

Create a free account (21+), then use code CAMERON. This link is the injectable form. Other forms are not interchangeable with it.

Shop injectable at AminoWell USA

Other forms at AminoWell USA

The short version

  • Why people research itTendon, gut and soft-tissue healing, angiogenesis and inflammation control.
  • What the evidence isNo completed randomized human trial, and it is worth being exact about why.
  • What to watchNew blurred or distorted vision.

How BPC-157 works

Cytoprotective peptide from gastric juice — upregulates VEGFR2/angiogenesis, nitric-oxide and growth-factor pathways to accelerate tendon, gut, muscle and nerve repair.

BPC-157 is fifteen residues long — Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a 1419 Da peptide with four prolines in the first eight positions and no cysteine anywhere. It is described everywhere as a fragment of a protein found in human gastric juice, and that description is doing more work than it can carry: no parent protein has ever been isolated, sequenced and deposited.

There is no cloned BPC-157 receptor. Not an orphan one, not a candidate one. For a compound sold on the strength of hundreds of rodent papers that is a genuinely unusual position, and it changes what counts as a mechanism here: you cannot write "binds X, activates Y", so the honest mechanism is the one experiment that measured a signaling event and named the proteins in it.

  • Injectable
  • Oral
  • Nasal

On the goal map: Gut lining & mucosal repair (Heal an injury)

Research on BPC-1575 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Human clinical evidence

  • No completed randomized human trial, and it is worth being exact about why. BPC-157 is a synthetic fragment of a gastric protein; it has no patentable composition worth the cost of a phase 3, and no sponsor has taken one on. A trial has been registered but there is no published human efficacy result.

    No completed human trial
  • The FDA moved it to the bulk-substances category 2 list in 2023, which restricts compounding — a regulatory judgement about the absence of data, not a finding of harm.

Correlative data

  • One of the most-used peptides in existence and the anecdotal record is correspondingly enormous, particularly for tendon, ligament and gut complaints. It is also the clearest case in the Vault of why anecdote is a weak instrument: soft-tissue injuries and gut flares both improve on their own, so a compound taken during recovery gets the credit either way.

How the mechanism reads

  • The animal literature is unusually broad and unusually consistent — accelerated tendon-to-bone healing, protection against NSAID-induced gut damage, and effects on the nitric-oxide system across many rodent models from largely one research group.

    Experimental, animal or cell
  • The proposed mechanism is upregulation of VEGF-driven angiogenesis and growth-factor receptor expression at the injury site. That same angiogenic mechanism is the reason for the one caution that actually matters here: anything that reliably grows new blood vessels is a question mark in the presence of an undiagnosed tumor, and nobody has studied that in humans.

    Mechanistic

Sources

  • Hsieh MJ, et al. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Scientific Reports 2020 · PMID 33051481
  • Seiwerth S, et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology 2021 · PMID 34267654
  • Brcic L, et al. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. Journal of Physiology and Pharmacology 2009 · PMID 20388964

BPC-157 safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Nitrate or PDE5-inhibitor use, or low blood pressure, since its documented action involves nitric oxide.
  • Active cancer or an undiagnosed lump, given VEGFR2-driven new vessel growth.
  • Proliferative diabetic retinopathy or other abnormal vessel growth in the eye.
  • Pregnancy or breastfeeding, where angiogenic signals matter for the fetus.

What’s expected

  • Warmth or a brief lightheaded feeling as vasomotor tone shifts.
  • Gradual comfort in tendon or gut complaints, based mainly on animal work.
  • Mild soreness where it is placed.

Watch for

  • New blurred or distorted vision.
  • A lump or mole that starts growing.
  • Fainting or sharp blood pressure falls on standing.

Labs that tell you it’s working

  • hs-CRP: shows whether the repair signal lowers background inflammation.
  • D-Dimer: a clot-turnover marker for a molecule that acts on vessel and platelet pathways in animals.
  • Fibrinogen Activity: tracks the coagulation side of the vascular effect.

Gastric pentadecapeptide acting through VEGFR2, nitric oxide and growth-factor pathways; harms are predicted from angiogenesis and vasomotor tone. PMID 33051481 PMID 20388964

Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON

BPC-157 FAQ4 common questions

Is BPC-157 approved for human use?
No. BPC-157 is a research compound. No completed randomized human trial has given it yet.
What is BPC-157 researched for?
Tendon, gut and soft-tissue healing, angiogenesis and inflammation control.
Which labs show whether it's doing anything?
hs-CRP; D-Dimer; Fibrinogen Activity: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for BPC-157: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what BPC-157 is. Skool covers how it is run.

Free on this page

What BPC-157 is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What BPC-157 is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The BPC-157 lesson: the protocol, step by step, with Cam's video
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool